Full Text
Full text is available in PDF
Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Hepatitis in The World
Authors
1Baqiyatallah Research Center for Gastroenterology and Liver Disease (BRCGL) Baqiyatallah University of Medical Sciences, Founder of Asian Hepatitis Network & Tehran Hepatitis Center, [email protected], Iran
*Corresponding Author: Baqiyatallah Research Center for Gastroenterology and Liver Disease (BRCGL) Baqiyatallah University of Medical Sciences, Founder of Asian Hepatitis Network & Tehran Hepatitis Center, [email protected], Iran. Tel: +9821 81264070. Fax: +9821 81264070. Email: [email protected]
How to Cite:Alavian S, E, H, B, N, et al. Hepatitis in The World. Hepat Mon. 2003;1(1):. doi:
Abstract
Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients.
Change of acute hepatitis B transmission routes in Japan.
A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C.
Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.
Hepatocellular carcinoma.
KeywordsArticle
Copyright
© 2003, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Sep
2009
Poor Response to Treatment with Peg-IFN Containing Regimens in Patients Coinfected with Hepatitis B and Hepatitis C Virus
Serpil Erol,
Zulal Ozkurt,
Ahmet Ozbek,
Mehmet Parlak
Erol S, Ozkurt Z, Ozbek A, Parlak M. Poor Response to Treatment with Peg-IFN Containing Regimens in Patients Coinfected with Hepatitis B and Hepatitis C Virus. Hepat Mon. 2009;9(3):. doi:
30
Sep
2004
Commentaries and points of view 2
Kamran Bagheri Lankarani,
Seyed Moayed Alavian
Bagheri Lankarani K, Alavian SM. Commentaries and points of view 2. Hepat Mon. 2004;4(8):e93016. doi:
1
Mar
2014
Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
Maryam Keshvari,
Seyed Moayed Alavian,
Heidar Sharafi,
Gharib Karimi,
Mohammad Gholami Fesharaki
Keshvari M, Alavian SM, Sharafi H, Karimi G, Gholami Fesharaki M. Interferon Alpha-2b Therapy in Chronic Hepatitis Delta. Hepat Mon. 2014;14(3):e15729. doi: https://doi.org/10.5812/hepatmon.15729
31
Aug
2011
Recent Advances in the Management of Chronic Hepatitis B
Soo Ryang Kim,
Jisin Yang,
Masatoshi Kudo,
Okio Hino
Kim SR, Yang J, Kudo M, Hino O. Recent Advances in the Management of Chronic Hepatitis B. Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.657
30
Sep
2011
Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran
Seyed Moayed Alavian,
Kamran B Lankarani,
Seyed Hossein Aalaei-Andabili,
Ali Pouryasin,
Nasser Daryani,
Mohsen Nasiritoosi
,et al.Alavian SM, B Lankarani K, Aalaei-Andabili SH, Pouryasin A, Daryani N, et al. Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran. Hepat Mon. 2011;11(9):e93018. doi:
Cited by
- Scopus by DOI: 0
Last Update: 4 days ago
- Scopus by Title: 0
Last Update: 4 days ago
- Scopus by Title (Ref): 0
Last Update: 4 days ago
- CrossRef: 0
Last Update: 6 days ago
Comments
Number of Comments:0